Vizient announces new agreement with RWJBarnabas Health

IRVING, Texas, June 26, 2024 – Vizient, Inc. today announced a new customer agreement with RWJBarnabas Health for a suite of data-enabled solutions and services in spend management and quality performance improvement. The agreement includes access to Vizient's industry-leading contract portfolio of medical devices, supplies and pharmaceuticals as well as analytics-enabled solutions to drive operational and clinical efficiencies.

"We are excited to welcome RWJBarnabas Health and share our comprehensive data-driven performance improvement resources," said Rand Ballard, chief customer officer, Vizient. "Working together, our expert-led solutions help providers meet their financial, market and quality improvement goals."

In addition to Vizient's contract portfolio, the agreement provides solutions to improve management in clinical operations resources, workforce optimization support and access to Vizient aggregations groups for increased savings.

Participation in the Vizient Clinical Data Base will enable RWJBarnabas Health to benchmark quality and financial performance with peer healthcare organizations. Using Vizient's Operational Data Base will provide comparative operational insights to reduce costs and pinpoint top performance.

"We are deeply committed to providing high quality care and value in operational performance across the system," said John Doll, chief operating officer, RWJBarnabas Health. "The Vizient benchmarking tools, including the Clinical Data Base, are providing us with real-time data from which we are better able to make more informed decisions with the goal of increasing quality and performance."

Vizient is the nation's largest provider-driven healthcare performance improvement company. Learn more about the Vizient Clinical Data Base.

About Vizient, Inc.

Vizient, Inc., the nation's largest provider-driven healthcare performance improvement company, serves more than 65% of the nation's acute care providers, including 97% of the nation's academic medical centers, and more than 35% of the non-acute market. The Vizient contract portfolio represents $140 billion in annual purchasing volume enabling the delivery of cost-effective, high-value care. With its acquisition of Kaufman Hall in 2024, Vizient expanded its advisory services to help providers achieve financial, strategic, clinical and operational excellence. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at www.vizientinc.com.